224 related articles for article (PubMed ID: 26667000)
1. The Many Neuroprogressive Actions of Tryptophan Catabolites (TRYCATs) that may be Associated with the Pathophysiology of Neuro-Immune Disorders.
Morris G; Carvalho AF; Anderson G; Galecki P; Maes M
Curr Pharm Des; 2016; 22(8):963-77. PubMed ID: 26667000
[TBL] [Abstract][Full Text] [Related]
2. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.
Maes M; Leonard BE; Myint AM; Kubera M; Verkerk R
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):702-21. PubMed ID: 21185346
[TBL] [Abstract][Full Text] [Related]
3. Schizophrenia: linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression.
Anderson G; Maes M
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Apr; 42():5-19. PubMed ID: 22800757
[TBL] [Abstract][Full Text] [Related]
4. Deficit Schizophrenia Is Characterized by Defects in IgM-Mediated Responses to Tryptophan Catabolites (TRYCATs): a Paradigm Shift Towards Defects in Natural Self-Regulatory Immune Responses Coupled with Mucosa-Derived TRYCAT Pathway Activation.
Kanchanatawan B; Sirivichayakul S; Ruxrungtham K; Carvalho AF; Geffard M; Anderson G; Maes M
Mol Neurobiol; 2018 Mar; 55(3):2214-2226. PubMed ID: 28290151
[TBL] [Abstract][Full Text] [Related]
5. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
[TBL] [Abstract][Full Text] [Related]
6. Overlapping the Tryptophan Catabolite (TRYCAT) and Melatoninergic Pathways in Alzheimer's Disease.
Maes M; Anderson G
Curr Pharm Des; 2016; 22(8):1074-85. PubMed ID: 25547097
[TBL] [Abstract][Full Text] [Related]
7. Deficit, but Not Nondeficit, Schizophrenia Is Characterized by Mucosa-Associated Activation of the Tryptophan Catabolite (TRYCAT) Pathway with Highly Specific Increases in IgA Responses Directed to Picolinic, Xanthurenic, and Quinolinic Acid.
Kanchanatawan B; Sirivichayakul S; Ruxrungtham K; Carvalho AF; Geffard M; Ormstad H; Anderson G; Maes M
Mol Neurobiol; 2018 Feb; 55(2):1524-1536. PubMed ID: 28181189
[TBL] [Abstract][Full Text] [Related]
8. IDO chronic immune activation and tryptophan metabolic pathway: A potential pathophysiological link between depression and obesity.
Chaves Filho AJM; Lima CNC; Vasconcelos SMM; de Lucena DF; Maes M; Macedo D
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):234-249. PubMed ID: 28595944
[TBL] [Abstract][Full Text] [Related]
9. Changes in Tryptophan Catabolite (TRYCAT) Pathway Patterning Are Associated with Mild Impairments in Declarative Memory in Schizophrenia and Deficits in Semantic and Episodic Memory Coupled with Increased False-Memory Creation in Deficit Schizophrenia.
Kanchanatawan B; Hemrungrojn S; Thika S; Sirivichayakul S; Ruxrungtham K; Carvalho AF; Geffard M; Anderson G; Maes M
Mol Neurobiol; 2018 Jun; 55(6):5184-5201. PubMed ID: 28875464
[TBL] [Abstract][Full Text] [Related]
10. IgA/IgM responses to tryptophan and tryptophan catabolites (TRYCATs) are differently associated with prenatal depression, physio-somatic symptoms at the end of term and premenstrual syndrome.
Roomruangwong C; Kanchanatawan B; Sirivichayakul S; Anderson G; Carvalho AF; Duleu S; Geffard M; Maes M
Mol Neurobiol; 2017 May; 54(4):3038-3049. PubMed ID: 27037573
[TBL] [Abstract][Full Text] [Related]
11. A New Schizophrenia Model: Immune Activation is Associated with the Induction of Different Neurotoxic Products which Together Determine Memory Impairments and Schizophrenia Symptom Dimensions.
Sirivichayakul S; Kanchanatawan B; Thika S; Carvalho AF; Maes M
CNS Neurol Disord Drug Targets; 2019; 18(2):124-140. PubMed ID: 30451122
[TBL] [Abstract][Full Text] [Related]
12. Bipolar Disorder: The Role of the Kynurenine and Melatonergic Pathways.
Anderson G; Jacob A; Bellivier F; Geoffroy PA
Curr Pharm Des; 2016; 22(8):987-1012. PubMed ID: 26654772
[TBL] [Abstract][Full Text] [Related]
13. Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway.
Kanchanatawan B; Sirivichayakul S; Thika S; Ruxrungtham K; Carvalho AF; Geffard M; Anderson G; Noto C; Ivanova R; Maes M
Metab Brain Dis; 2017 Aug; 32(4):1003-1016. PubMed ID: 28258445
[TBL] [Abstract][Full Text] [Related]
14. The tryptophan catabolite or kynurenine pathway in autism spectrum disorder; a systematic review and meta-analysis.
Almulla AF; Thipakorn Y; Tunvirachaisakul C; Maes M
Autism Res; 2023 Dec; 16(12):2302-2315. PubMed ID: 37909397
[TBL] [Abstract][Full Text] [Related]
15. Anxiety Disorders: Sex Differences in Serotonin and Tryptophan Metabolism.
Songtachalert T; Roomruangwong C; Carvalho AF; Bourin M; Maes M
Curr Top Med Chem; 2018; 18(19):1704-1715. PubMed ID: 30430940
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
17. Depressive, anxiety and hypomanic symptoms in schizophrenia may be driven by tryptophan catabolite (TRYCAT) patterning of IgA and IgM responses directed to TRYCATs.
Kanchanatawan B; Sirivichayakul S; Carvalho AF; Anderson G; Galecki P; Maes M
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):205-216. PubMed ID: 28690204
[TBL] [Abstract][Full Text] [Related]
18. Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis.
Myint AM; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():304-13. PubMed ID: 24184687
[TBL] [Abstract][Full Text] [Related]
19. Body image dissatisfaction in pregnant and non-pregnant females is strongly predicted by immune activation and mucosa-derived activation of the tryptophan catabolite (TRYCAT) pathway.
Roomruangwong C; Kanchanatawan B; Carvalho AF; Sirivichayakul S; Duleu S; Geffard M; Maes M
World J Biol Psychiatry; 2018 Apr; 19(3):200-209. PubMed ID: 27427239
[TBL] [Abstract][Full Text] [Related]
20. The Tryptophan Catabolite or Kynurenine Pathway in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
Almulla AF; Supasitthumrong T; Amrapala A; Tunvirachaisakul C; Jaleel AKA; Oxenkrug G; Al-Hakeim HK; Maes M
J Alzheimers Dis; 2022; 88(4):1325-1339. PubMed ID: 35786655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
